Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
- 9 May 2008
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 436 (2), 269-272
- https://doi.org/10.1016/j.neulet.2008.03.041
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of cocaine in 5-lipoxygenase-deficient miceJournal of Neural Transmission, 2008
- Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapyMedical Hypotheses, 2007
- 5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cellsProstaglandins & Other Lipid Mediators, 2007
- 5‐Lipoxygenase gene disruption reduces amyloid‐β pathology in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2007
- 5-Lipoxygenase as a Possible Biological Link Between Depressive Symptoms and AtherosclerosisArchives of General Psychiatry, 2007
- The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5‐lipoxygenase productsBritish Journal of Pharmacology, 2007
- The 5-lipoxygenase enzymatic pathway in the mouse brain: Young versus oldNeurobiology of Aging, 2007
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid ReceptorsBiological Psychiatry, 2007
- 5-Lipoxygenase: Regulation and possible involvement in atherosclerosisProstaglandins & Other Lipid Mediators, 2007
- 5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivoBrain Research, 2007